
EDQM Releases Document on Recombinant Viral Vectored Vaccines for COVID-19
The document provides analytical strategy options for the control of recombinant viral vectored vaccines to support COVID-19 vaccine developers.
The European Directorate for the Quality of Medicines and HealthCare (EDQM)
The document, titled “
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.